NYSE American · ELMDHealthcareElectromedical Equipment

Electromed, Inc. (ELMD)

$28.01+4.83%
Close Nov 4, 2026 · split-adjusted
Nov 3, 2026$26.72▲ 11.10% in range
Nov 3, 2025Low $23.15 · High $46.31Nov 3, 2026
What changed · written from our data
As of Nov 4, 2026

Electromed closed at $28.01 on Nov 4, up 4.83%, 39.5% below its 52-week closing high. Volume of 42.9K shares was 0.85× its 20-day average (close to normal).

Split-adjusted performance: -0.9% over one month, +8.0% over six months, +16.5% over one year.

In the quarter ended Jun 30, 2026, revenue was $19.42M, up 11.6% from a year earlier, with a net margin of 17.5%.

Short interest was 194.3K shares at the Oct 15 settlement, down 4.9% from the prior report (2.9% of float, 2.6 days to cover).

Market cap$232.1M8.3M shares
Revenue · quarter$19.4M+11.6% YoY
Diluted EPS$0.39+56.0% YoY
P/E · TTM20.5×P/S 3.1×
Net margin17.5%Gross 78.7%
Dividend yieldNone
52-week range23.15 – 46.31−39.5% from high
Volume42.9K0.85× 20-day avg
Volatility · 60d52.9%Annualised
Short % of float2.9%2.6 days to cover
Net cash$20.4MCash $20.4M
Next earnings—Not scheduled
Split-adjusted performance
1W +2.7%1M −0.9%3M −33.4%6M +8.0%YTD −3.8%1Y +16.5%3Y +167.2%5Y +158.6%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Electromedical Equipment

Percentile among 22 companies (100 = best)

6-month momentum67
Revenue growth41
Net margin95
Value (low P/E)—
Size62

Industry medians: 6-month return −0.9%, revenue growth +13.9%, net margin −44.6%, P/E 23.7×.

Short interest

Details →
Shares short194.3K−4.9% vs prior
Days to cover2.6Settled Oct 15
% of float2.9%
Short vol. 10d47.8%of daily volume

Closest peers by size in Electromedical Equipment

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
ELMDElectromed$28.01+4.83%+8.0%+11.6%17.5%20.5$232.1M
CVCapsoVision$6.85+2.24%−2.3%—−205.4%—$364.5MCompare
VANIVivani Medical, Inc. Common Stock (DE)$1.07+1.90%−14.4%———$96.5MCompare
STXSStereotaxis$0.9572+13.55%−50.1%−12.8%−62.3%—$95.9MCompare
NRXSNeuraxis$6.86+4.26%−22.1%+115.7%−118.1%—$86.1MCompare
OMOutset Medical$4.44+6.99%−1.6%+0.7%−56.8%—$83.5MCompare
HYPRHyperfine$0.7503+8.36%−56.6%+44.8%−238.2%—$79.6MCompare
ECORelectroCore$8.40+16.18%+26.1%+28.0%−32.4%—$75.7MCompare
POCIPrecision Optics$4.84+3.42%+2.8%+42.0%−1.2%—$53.2MCompare

News about Electromed

All news →

No recent articles focused on Electromed.

Quick answers

What does Electromed do?
Electromed Inc is a United States-based company that develops, manufactures and markets airway clearance products that apply High Frequency Chest Wall Oscillation (HFCWO) therapy in pulmonary care for patients of all ages. The company markets its products in the U.S.
What is ELMD's market cap?
$232.12M, based on the Nov 4 close of $28.01.
What is ELMD's P/E ratio?
20.5× trailing-twelve-month earnings of $11.30M.
Does Electromed pay a dividend?
No regular cash dividend has been paid in the last year.
How much of ELMD is sold short?
194.3K shares, 2.9% of float, as of Oct 15, 2026.
What sector is ELMD in?
Healthcare, in the Electromedical Equipment industry.

About Electromed

Electromed Inc is a United States-based company that develops, manufactures and markets airway clearance products that apply High Frequency Chest Wall Oscillation (HFCWO) therapy in pulmonary care for patients of all ages. The company markets its products in the U.S. to the homecare and hospital markets. Its product includes the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The company operates in a single segment: developing, manufacturing, and marketing medical equipment. The company generates revenue from Homecare, Hospital, Homecare Distributor, and Other.

HQ: New Prague, MN197 employeesListed Aug 13, 2010smartvest.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology